secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2022-02-01T23:59:59+00:00
Accession:  0001493152-22-002893
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics enters employment agreement with CFO Nir Sassi; base salary $345,000
--------------------------------------------------------------------------------

- Annual base salary of $345,000 with annual review; eligible for target bonus up to 40% of base salary.
- Prior consulting agreement terminated; separately agreed to pay $195,728 termination payment to Mr. Sassi.
- Severance of 12 months base salary if terminated without cause or resigns for good reason.
- Change-in-control severance: 12 months base plus target bonus, plus accelerated equity vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315222002893/0001493152-22-002893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315222002893/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-002893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer